Fundraising Fox
Alex Mayweg
InvestorManaging Director at Versant Ventures
Basel, Switzerland
Writes $100K – $5M checks · typically $1.5M
Find your path to Alex
Sign up to see every warm intro you have to Alex
- Paths you didn't know you had: your email and LinkedIn already hold routes to Alex. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Managing Director at Versant and head of Ridgeline Therapeutics, Versant's Basel-based Discovery Engine, with deep experience in drug discovery and medicinal chemistry. He previously served as global head of chemistry at Roche over a 14-year career and holds a Ph.D. in organic chemistry from Oxford, with post-doctoral training at Stanford and an undergraduate degree from Imperial College London.
Contact· self-published, not guessed
Deals · 3
Firefly Bio, Inc.Board seat
via Versant Ventures · filed Mar 2024 · $72M raise
Bright Peak TherapeuticsBoard seat
via Versant Ventures · filed Jun 2021 · $106.5M raise
Aset TherapeuticsBoard seat
via Versant Ventures · filed Jan 2018 · $12.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
Antag TherapeuticsBlack Diamond TherapeuticsCimeio TherapeuticsEnterprise TherapeuticsLaunchpad Therapeutics, Inc.Matterhorn BiosciencesMonte Rosa TherapeuticsSixPeaks BioT-KnifeVector BioPharma
Sources: SEC Form D filings · curated public sources.
Colleagues at Versant Ventures
Network10
Investors connected to Alex in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Alex Mayweg?
- Managing Director at Versant and head of Ridgeline Therapeutics, Versant's Basel-based Discovery Engine, with deep experience in drug discovery and medicinal chemistry. He previously served as global head of chemistry at Roche over a 14-year career and holds a Ph.D. in organic chemistry from Oxford, with post-doctoral training at Stanford and an undergraduate degree from Imperial College London.
- Where does Alex Mayweg work?
- Alex Mayweg is Managing Director at Versant Ventures.
- What check size does Alex Mayweg write?
- Alex Mayweg typically writes checks of $100K – $5M.
- What boards does Alex Mayweg sit on?
- Alex Mayweg holds tracked board seats at Aset Therapeutics, Bright Peak Therapeutics, Firefly Bio, Inc..
- What companies has Alex Mayweg invested in?
- Investments tracked here include Antag Therapeutics, Black Diamond Therapeutics, Bright Peak Therapeutics, Cimeio Therapeutics, Enterprise Therapeutics, Launchpad Therapeutics, Inc., Matterhorn Biosciences, Monte Rosa Therapeutics, SixPeaks Bio, T-Knife, Vector BioPharma.
About this profile. Compiled from public sources — Versant Ventures's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights